The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
the Alzheimer trial has no name the Alzheimer trial is a trial in oh it's a fourth try it's a fourth trial yes it's a four trial but we have no name for it because it's in a single Center in Amsterdam where we have basically mild cognitive impairment with the diagnosis of Alzheimer's so early Alzheimer we give them our drug and be serially measure both blood and CSF by spinal taps
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.